All Stories

  1. Comparison of Transient Elastography and Point Shear Wave Elastography for Analysis of Liver Stiffness: A Prospective Study
  2. Investigating the prilling/vibration technique to produce gastric-directed drug delivery systems for misoprostol
  3. Author's Reply: “NRF2 in cancer: An insufficiently explored and controversial research area”
  4. Natural History and Hepatitis B Virus Surface Antigen (HBsAg) Spontaneous Seroclearance in Hepatitis B Virus e-Antigen (HBeAg)-Negative Patients with Inactive Chronic Infection: A Multicenter Regional Study from South Italy
  5. Malnutrition assessment by Global Leadership Initiative on Malnutrition criteria in patients with amyotrophic lateral sclerosis
  6. Effect of Long-Term Proton Pump Inhibitor Use on Blood Vitamins and Minerals: A Primary Care Setting Study
  7. Risk of obesity during a gluten-free diet in pediatric and adult patients with celiac disease: a systematic review with meta-analysis
  8. Esophageal Eosinophilia and Eosinophilic Esophagitis in Celiac Children: A Ten Year Prospective Observational Study
  9. Minimal portosystemic encephalopathy: A new nosological entity in patients with hereditary haemorrhagic telangiectasia
  10. Twelve Months with COVID-19: What Gastroenterologists Need to Know
  11. Iodine Absorption in Celiac Children: A Longitudinal Pilot Study
  12. Probiotics and intestinal inflammation
  13. Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study
  14. Trends of Liver Stiffness in Inflammatory Bowel Disease with Chronic Hepatitis C
  15. Chronic Viral Hepatitis in a Cohort of Inflammatory Bowel Disease Patients from Southern Italy: A Case-Control Study
  16. Advances in understanding the potential therapeutic applications of gut microbiota and probiotic mediated therapies in celiac disease
  17. Soy Metabolism by Gut Microbiota from Patients with Precancerous Intestinal Lesions
  18. Evaluation of Non-Celiac Gluten Sensitivity in Patients with Previous Diagnosis of Irritable Bowel Syndrome: A Randomized Double-Blind Placebo-Controlled Crossover Trial
  19. Gut Microbiota Imbalance is Related to Sporadic Colorectal Neoplasms. A Pilot Study
  20. Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease
  21. Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement
  22. Phytoestrogens: Dietary Intake, Bioavailability, and Protective Mechanisms against Colorectal Neoproliferative Lesions
  23. The Spectrum of Small Intestinal Lesions in Patients with Unexplained Iron Deficiency Anemia Detected by Video Capsule Endoscopy
  24. Can the Antisecretory Factor Be Considered a New Therapy for the Short Bowel Syndrome?
  25. Predictivity of Autoimmune Stigmata for Gluten Sensitivity in Subjects with Microscopic Enteritis: A Retrospective Study
  26. Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors
  27. Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapy
  28. Is the use of the BMI alone sufficient to diagnose malnutrition in both male and female adults?
  29. Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials
  30. Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis
  31. Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm
  32. Histamine and Histaminergic Receptors in Colorectal Cancer: From Basic Science to Evidence-based Medicine
  33. Probiotic monotherapy andHelicobacter pylorieradication: A systematic review with pooled-data analysis
  34. Letter: dose-response analysis revealed closer relationship between obesity and perioperative outcomes in patients after liver transplantation-Authors’ reply
  35. Hepatitis C Virus Clearance in Older Adults
  36. Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn’s Disease: A Systematic Review of Randomized Trials
  37. Influence of chemotherapy on total energy expenditure in patients with gastrointestinal cancer: A pilot study
  38. Obesity as predictor of postoperative outcomes in liver transplant candidates: Review of the literature and future perspectives
  39. HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study
  40. Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease
  41. A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study
  42. Editorial: liver transplantation in patients with non-alcoholic fatty liver disease and obesity-authors’ reply
  43. Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study
  44. Systematic review with meta-analysis: post-operative complications and mortality risk in liver transplant candidates with obesity
  45. Epstein-Barr Virus-Related Hyperacute Hepatitis: May Intravenous Steroids be an Effective Approach?
  46. Sequential Therapy For Helicobacter pylori in Elderly Patients: Effectiveness, Safety and Predictors of Success
  47. Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis
  48. Letter: can transient elastography and body mass index predict fibrosis regression in HBV patients on long-term nucleoside therapy?
  49. Update on the Medical Management of Gastrointestinal Behçet’s Disease
  50. Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: what needs to be explored?
  51. Noninvasive molecular analysis ofHelicobacter pylori: Is it time for tailored first-line therapy?
  52. Helicobacter pylori, liver cirrhosis, and portal hypertension: an updated appraisal
  53. Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients?
  54. Helicobacter pyloriDNA isolation in the stool: an essential pre-requisite for bacterial noninvasive molecular analysis
  55. Prognostic role of 25-hydroxyvitamin D in patients with liver metastases from colorectal cancer treated with radiofrequency ablation
  56. Lovastatin, but not orlistat, reduces intestinal polyp volume in an ApcMin/+ mouse model
  57. Acute pancreatitis in elderly patients: A retrospective evaluation at hospital admission
  58. Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis
  59. Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma
  60. May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis?
  61. Role of concomitant therapy forHelicobacter pylorieradication: A technical note
  62. Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association
  63. Multistage vector delivery of sulindac and silymarin for prevention of colon cancer
  64. Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients
  65. Medical Systemic Therapies for Hepatocellular Carcinoma: Clinical Perspectives and Safety Profile
  66. Seronegative Celiac Disease and Immunoglobulin Deficiency: Where to Look in the Submerged Iceberg?
  67. Polidocanol injection decreases the bleeding rate after colon polypectomy: a propensity score analysis
  68. A comparison of the nutritional status between adult celiac patients on a long-term, strictly gluten-free diet and healthy subjects
  69. Combination Therapy With Sorafenib and Radiofrequency Ablation for Hepatocellular Carcinoma: A Glimmer of Light after the Storm Trial?
  70. MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma
  71. Neurophysiologic and Psychometric Tests in the Diagnosis of Low-Grade Encephalopathy
  72. Biologic drugs in rheumatologic patients who experienced HBV infection
  73. Letter: prognostic scoring systems for hepatocellular carcinoma patients - the jury is still out
  74. Liver stiffness and portal blood flow modifications induced by a liquid meal consumption: pathogenetic mechanisms and clinical relevance
  75. Conditional survival analysis of hepatocellular carcinoma patients treated with radiofrequency ablation
  76. Endothelial Dysfunction Correlates with Liver Fibrosis in Chronic HCV Infection
  77. Echoendoscopic ethanol ablation of tumor combined to celiac plexus neurolysis improved pain control in a patient with pancreatic adenocarcinoma
  78. Non-polypoid colorectal neoplasms: Classification, therapy and follow-up
  79. Role of Bone Marrow-Derived Stem Cells in Polyps Development in Mice with ApcMin/+Mutation
  80. Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients
  81. Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation
  82. Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation
  83. An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C
  84. Transient GFER knockdown in vivo impairs liver regeneration after partial hepatectomy
  85. Olive oil and omega-3 polyunsaturated fatty acids suppress intestinal polyp growth by modulating the apoptotic process in ApcMin/+ mice
  86. Bone marrow-derived stem cells and hepatocarcinogenesis in hepatitis B virus transgenic mice
  87. Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin
  88. Ulcerative colitis: From inflammation to cancer. Do estrogen receptors have a role?
  89. HBsAg clearance by Peg-interferon addition to a long-term nucleos(t)ide analogue therapy
  90. Role of vaptans in the management of hydroelectrolytic imbalance in liver cirrhosis
  91. Variation in genes encoding for interferon λ-3 and λ-4 in the prediction of HCV-1 treatment-induced viral clearance
  92. Influence of Age and Type of Underlying Disease on Complications Related to Home Enteral Nutrition
  93. Disseminated tumour cells in bone marrow in experimental colon cancer: metastatic or resident?
  94. Estrogen Receptor beta in Colorectal Cancer Prevention: Do we have Conclusive Proof?
  95. Altered molecular pattern of mucosal healing in Crohn’s disease fibrotic stenosis
  96. Phytoestrogens/insoluble fibers and colonic estrogen receptor β: Randomized, double-blind, placebo-controlled study
  97. Lesson from an intriguing case of cryoglobulinemia
  98. Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit
  99. Estrogen receptors expression in long-lasting ulcerative pancolitis with and without dysplasia: A preliminary report
  100. Phytoestrogens as Nutritional Modulators in Colon Cancer Prevention
  101. Erratum to: Dietary, Endocrine, and Metabolic Factors in the Development of Colorectal Cancer
  102. Dietary, Endocrine, and Metabolic Factors in the Development of Colorectal Cancer
  103. Anti-Viral Therapy in Chronic HBV Infection: A Single Centre Experience
  104. Donor Risk Index and MELD Score Interactions in Graft Survival Prediction after Liver Transplantation. An Analysis of the OPTN-UNOS Database
  105. Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury
  106. ERβ expression in normal, adenomatous and carcinomatous tissues of patients with familial adenomatous polyposis
  107. Dietary-induced ER  upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice
  108. androgens and hepatocarcinoma
  109. Effect of gonadectomy on HCC development in HBV transgenic mice
  110. ER-β expression in large bowel adenomas: Implications in colon carcinogenesis
  111. Estrogens, phytoestrogens and colorectal neoproliferative lesions
  112. ABO Blood Group-Related Waiting List Disparities in Liver Transplant Candidates: Effect of the MELD Adoption
  113. Allocation of Nonstandard Livers to Transplant Candidates With High MELD Scores: Should This Practice Be Continued?
  114. ALLOCATION OF NON-STANDARD LIVERS TO LIVER TRANSPLANT CANDIDATES WITH HIGH MELD VALUES: SHOULD THIS PRACTICE BE CONTINUED?
  115. Use of “O” Blood Group Liver Donors for Nonidentical Recipients: Does This Represent a Double Penalty for “O” Blood Group Candidates?
  116. Estrogen-Induced Proliferation in Cultured Hepatocytes Involves Cyclin D1, P21CIP1 and P27KIP1
  117. Functional modification of CD11c+ liver dendritic cells during liver regeneration after partial hepatectomy in mice
  118. Sliding gastric hiatal hernia diagnosis by transabdominal ultrasonography: An easy, reliable and non-invasive procedure
  119. P.044 Organ specific gene expression profile reflect distinguished pathogenesis in liver and kidney during HBV persistence — a study in HBV transgenic mouse model
  120. Small Intestinal Contrast Ultrasonography-Based Scoring System
  121. Detection of Alkaline Sphingomyelinase Activity in Human Stool: Proposed Role as a New Diagnostic and Prognostic Marker of Colorectal Cancer
  122. Hepatitis D–related Cirrhosis and Risk of Hepatocellular Carinoma Development
  123. Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure
  124. Mycophenolate mofetil in the treatment of autoimmune HCV-associated haematological disorders showing steroid resistance or dependence
  125. Influence of ursodeoxycholate-enriched diet on liver tumor growth in HBV transgenic mice
  126. Second harmonic imaging improves trans-abdominal ultrasound detection of biliary sludge in ‘idiopathic’ pancreatitis
  127. Tumor Necrosis Factor Alpha and Apoptosis in Helicobacter pylori Related Progressive Gastric Damage: A Possible Mechanism of Immune System Involvement in Epithelial Turnover Regulation
  128. Demonstration of a Direct Stimulatory Effect of Bile Salts on Rat Colonic Epithelial Cell Proliferation
  129. Augmenter of liver regeneration is a mitochondrial sulfhydryl oxidase
  130. Analysis of individual items of mini-mental state examination in discrimination between normal and demented subjects
  131. Modulation of rat hepatocyte proliferation by bile salts: In vitro and In vivo studies
  132. Small-for-size liver transplanted into larger recipient: A model of hepatic regeneration
  133. Small-for-size liver transplanted into larger recipient: A model of hepatic regeneration
  134. Hepatic stimulatory substance (HSS) in liver regeneration
  135. Effect of Epomediol on Taurocholate Uptake in Hepatocytes Isolated from Normal Rats or Rats with Ethinyloestradiol-Induced Cholestasis
  136. Hepatic regeneration and growth factors
  137. Studies in vitro on the influence of ursodeoxycholate sodium salt (UDC) on hepatocyte proliferation
  138. Screening for candidate hepatic growth factors by selective portal infusion after canine Eck's fistula
  139. Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506
  140. Further steps of hepatic stimulatory substance purification
  141. Relationship between plasma and hepatic cytosolic levels of ornithine decarboxylase (ODC) and thymidine kinase (TK) in 70% hepatectomized rats
  142. Effect of ranitidine on acetaminophen-induced hepatotoxicity in dogs
  143. AUGMENTATION OF RAT LIVER REGENERATION BY FK 506 COMPARED WITH CYCLOSPORIN
  144. Estradiol and testosterone levels in patients undergoing partial hepatectomy
  145. Psychomotor dysfunctions in alcoholic and post-necrotic cirrhotic patients without overt encephalopathy
  146. The effect of estrogen and tamoxifen on hepatocyte proliferationin Vivo andin Vitro
  147. A Dog Model for Acetaminophen-Induced Fulminant Hepatic Failure
  148. Effect of cimetidine, ranitidine, famotidine and omeprazole on hepatocyte proliferation in vitro
  149. Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissue
  150. Effect of spironolactone and potassium canrenoate on cytosolic and nuclear androgen and estrogen receptors of rat liver